Abstract
Formycin B is metabolized by cutaneous Leishmania amastigotes within cultured human macrophages to give formycin B 5'-monophosphate and formycin A 5'-mono-, di-, and triphosphates. Formycin A is also incorporated into RNA. The activity of formycin B against amastigotes was correlated with the levels of formycin A metabolites formed in the parasites. Uninfected macrophages also convert formycin B into the same products, but the levels are markedly lower than those seen in infected macrophages. The results suggest that a sufficient therapeutic index exists to warrant consideration of formycin B as an anti-leishmanial drug in humans.
Full Text
The Full Text of this article is available as a PDF (328.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berman J. D., Dwyer D. M., Wyler D. J. Multiplication of Leishmania in human macrophages in vitro. Infect Immun. 1979 Oct;26(1):375–379. doi: 10.1128/iai.26.1.375-379.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berman J. D. In vitro susceptibility of antimony-resistant Leishmania to alternative drugs. J Infect Dis. 1982 Feb;145(2):279–279. doi: 10.1093/infdis/145.2.279. [DOI] [PubMed] [Google Scholar]
- Berman J. D., Wyler D. J. An in vitro model for investigation of chemotherapeutic agents in leishmaniasis. J Infect Dis. 1980 Jul;142(1):83–86. doi: 10.1093/infdis/142.1.83. [DOI] [PubMed] [Google Scholar]
- Carson D. A., Chang K. P. Phosphorylation and anti-leishmanial activity of formycin B. Biochem Biophys Res Commun. 1981 Jun 16;100(3):1377–1383. doi: 10.1016/0006-291x(81)91976-8. [DOI] [PubMed] [Google Scholar]
- Khym J. X. An analytical system for rapid separation of tissue nucleotides at low pressures on conventional anion exchangers. Clin Chem. 1975 Aug;21(9):1245–1252. [PubMed] [Google Scholar]
- Nelson D. J., Lafon S. W., Jones T. E., Spector T., Berens R. L., Marr J. J. The metabolism of formycin B in Leishmania donovani. Biochem Biophys Res Commun. 1982 Sep 16;108(1):349–354. doi: 10.1016/0006-291x(82)91873-3. [DOI] [PubMed] [Google Scholar]
- Rainey P., Santi D. V. Metabolism and mechanism of action of formycin B in Leishmania. Proc Natl Acad Sci U S A. 1983 Jan;80(1):288–292. doi: 10.1073/pnas.80.1.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Umezawa H., Sawa T., Fukagawa Y., Homma I., Ishizuka M. Studies on formycin and formycin B in cells of Ehrlich carcinoma and E. coli. J Antibiot (Tokyo) 1967 Nov;20(6):308–316. [PubMed] [Google Scholar]